
Pediatrix Medical (MD) | Stock Overview & Key Data
Pediatrix Medical Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $86.09 on August 17, 2015
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Pediatrix Medical MD | 1.15B Small-cap | -1.60% | -4.03% | -3.83% | 9.00% | 4.07% | 82.30% | -42.81% | -29.00% |
HCA Healthcare HCA | 91.04B Large-cap | 0.11% | 1.46% | 11.79% | 24.97% | 27.10% | 16.43% | 120.03% | 256.02% |
Tenet Healthcare THC | 15.71B Large-cap | -0.48% | 3.13% | 30.77% | 33.94% | 36.88% | 28.28% | 210.33% | 655.10% |
Select Medical SEM | 1.85B Small-cap | -3.90% | -6.13% | -14.42% | -20.42% | -22.62% | -26.53% | 4.36% | 85.27% |
National Healthcare NHC | 1.65B Small-cap | -4.62% | -0.69% | 10.79% | 7.11% | -2.57% | -14.45% | 46.77% | 62.79% |
Pacs PACS | 2.05B Mid-cap | -1.53% | 23.34% | 28.92% | 0.08% | -0.70% | -58.27% | -46.08% | -46.08% |
Ownership & Short Interest
Pediatrix Medical Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Pediatrix Medical would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
What is MD's 52-week high and low?
In the last 52 weeks, Pediatrix Medical reached a high of $17.67 (on February 20, 2025) and a low of $6.62 (on July 9, 2024).
What is the market cap and P/E ratio for MD?
Curious about Pediatrix Medical's size and valuation? Its market capitalization stands at 1.15B. When it comes to valuation, the P/E ratio (trailing twelve months) is 7.98, and the forward P/E (looking ahead) is 8.74.
Does MD pay dividends? If so, what's the yield?
As for dividends, Pediatrix Medical isn't currently offering a significant yield, or that specific data isn't available right now.
Who are Pediatrix Medical's main competitors or similar companies to consider before investing?
When looking at Pediatrix Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company | Mkt Cap | Sector | Industry | 1Y Return | 3Y Return |
---|---|---|---|---|---|
HCA Healthcare HCA | 91.04B | Healthcare | Medical Care Facilities | 16.43% | 120.03% |
Tenet Healthcare THC | 15.71B | Healthcare | Medical Care Facilities | 28.28% | 210.33% |
Select Medical SEM | 1.85B | Healthcare | Medical Care Facilities | -26.53% | 4.36% |
National Healthcare NHC | 1.65B | Healthcare | Medical Care Facilities | -14.45% | 46.77% |
Pacs PACS | 2.05B | Healthcare | Medical Care Facilities | -58.27% | -46.08% |
For a more comprehensive list, please see the Peer Performance Comparison table on this page.
What are the key financial health indicators for Pediatrix Medical Group, Inc.? (e.g., ROE, Debt/Equity)
To get a sense of Pediatrix Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -10.01%, the Debt to Equity ratio from the most recent quarter is 83.04, and its Gross Profit Margin stands at 22.39%.
What is the recent revenue and earnings growth for MD?
Looking at Pediatrix Medical's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by -7.40%, and quarterly earnings saw a YoY growth of 413.90%.
How much of MD stock is held by insiders and institutions?
Wondering who owns Pediatrix Medical stock? Company insiders (like executives and directors) hold about 2.11% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 92.23%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.